BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 29186769)

  • 1. Models in the Research Process of Psoriasis.
    Bocheńska K; Smolińska E; Moskot M; Jakóbkiewicz-Banecka J; Gabig-Cimińska M
    Int J Mol Sci; 2017 Nov; 18(12):. PubMed ID: 29186769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Murine models of psoriasis and its applications in drug development.
    Luo T; Ma Y; Wei W
    J Pharmacol Toxicol Methods; 2020; 101():106657. PubMed ID: 31751654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Animal models of psoriasis: a critical appraisal.
    Schön MP
    Exp Dermatol; 2008 Aug; 17(8):703-12. PubMed ID: 18557923
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Getting under the skin: the immunogenetics of psoriasis.
    Bowcock AM; Krueger JG
    Nat Rev Immunol; 2005 Sep; 5(9):699-711. PubMed ID: 16138103
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contribution of
    Lorthois I; Asselineau D; Seyler N; Pouliot R
    Mediators Inflamm; 2017; 2017():7215072. PubMed ID: 29249871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Animal models of psoriasis and pustular psoriasis.
    Mizutani H; Yamanaka K; Konishi H; Murakami T
    Arch Dermatol Res; 2003 Apr; 295 Suppl 1():S67-8. PubMed ID: 12677436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Upregulation of ANGPTL6 in mouse keratinocytes enhances susceptibility to psoriasis.
    Tanigawa H; Miyata K; Tian Z; Aoi J; Kadomatsu T; Fukushima S; Ogata A; Takeda N; Zhao J; Zhu S; Terada K; Endo M; Morinaga J; Sugizaki T; Sato M; Morioka MS; Manabe I; Mashimo Y; Hata A; Taketomi Y; Yamamoto K; Murakami M; Araki K; Jinnin M; Ihn H; Oike Y
    Sci Rep; 2016 Oct; 6():34690. PubMed ID: 27698489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Xenotransplantation Model of Psoriasis.
    Di Domizio J; Conrad C; Gilliet M
    Methods Mol Biol; 2017; 1559():83-90. PubMed ID: 28063039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The search for pathogenic T cells and the genetic basis of psoriasis using a severe combined immunodeficient mouse model.
    Nickoloff BJ
    Cutis; 2000 Feb; 65(2):110-4. PubMed ID: 10696565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. What must a model display for proof as a model of psoriasis?
    Sterry W; Foerster J
    Ernst Schering Res Found Workshop; 2005; (50):193-201. PubMed ID: 15526943
    [No Abstract]   [Full Text] [Related]  

  • 11. Role of IL-17A signalling in psoriasis and associated bone loss.
    Uluçkan Ö; Wagner EF
    Clin Exp Rheumatol; 2016; 34(4 Suppl 98):17-20. PubMed ID: 27586798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Psoriasis SCID-mouse model].
    Pfeffer J; Kaufmann R; Boehncke WH
    Hautarzt; 2006 Jul; 57(7):603-9. PubMed ID: 16028077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isoliquiritigenin prevents the progression of psoriasis-like symptoms by inhibiting NF-κB and proinflammatory cytokines.
    Wu Y; Chen X; Ge X; Xia H; Wang Y; Su S; Li W; Yang T; Wei M; Zhang H; Gou L; Li J; Jiang X; Yang J
    J Mol Med (Berl); 2016 Feb; 94(2):195-206. PubMed ID: 26383911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The immunology of psoriasis: from basic research to the bedside].
    Gyulai R; Kemény L
    Orv Hetil; 2006 Nov; 147(46):2213-20. PubMed ID: 17396393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implantable synthetic cytokine converter cells with AND-gate logic treat experimental psoriasis.
    Schukur L; Geering B; Charpin-El Hamri G; Fussenegger M
    Sci Transl Med; 2015 Dec; 7(318):318ra201. PubMed ID: 26676608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lifting the silver flakes: the pathogenesis and management of chronic plaque psoriasis.
    Chong HT; Kopecki Z; Cowin AJ
    Biomed Res Int; 2013; 2013():168321. PubMed ID: 24062996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of TNF-α converting enzyme in the development of psoriasis-like lesions in a mouse model.
    Sato K; Takaishi M; Tokuoka S; Sano S
    PLoS One; 2014; 9(11):e112408. PubMed ID: 25384035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mouse models of psoriasis.
    Gudjonsson JE; Johnston A; Dyson M; Valdimarsson H; Elder JT
    J Invest Dermatol; 2007 Jun; 127(6):1292-308. PubMed ID: 17429444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathogenic role for skin macrophages in a mouse model of keratinocyte-induced psoriasis-like skin inflammation.
    Stratis A; Pasparakis M; Rupec RA; Markur D; Hartmann K; Scharffetter-Kochanek K; Peters T; van Rooijen N; Krieg T; Haase I
    J Clin Invest; 2006 Aug; 116(8):2094-104. PubMed ID: 16886058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting miR-21 to treat psoriasis.
    Guinea-Viniegra J; Jiménez M; Schonthaler HB; Navarro R; Delgado Y; Concha-Garzón MJ; Tschachler E; Obad S; Daudén E; Wagner EF
    Sci Transl Med; 2014 Feb; 6(225):225re1. PubMed ID: 24574341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.